Carbamide Synthesis via Segmented Crystallization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide face challenges in achieving high purity and yield due to the formation of undesirable impurities and require improved processes for crystallization and purification.
Innovation Solution
A method involving the reaction of 4-hydroxybenzaldehyde with isobutylbromide, followed by conversion to 4-isobutoxybenzaldehyde, oxime, and subsequent steps using Raney-Ni and excess ammonia, culminating in the formation of the carbamide with controlled crystallization to obtain crystalline Form C, which minimizes impurities and enhances purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional synthesis methods are used to produce N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide, then the production process is simpler, but the purity is reduced due to formation of undesirable impurities
Solution Approach 1:
The synthesis process is divided into multiple discrete steps with specific purification interventions at each stage. The multi-step synthesis includes separate reactions for forming the carbamide bond, followed by distinct crystallization steps to remove different types of impurities, thereby achieving high purity through segmented processing rather than a single complex operation
Solution Approach 2:
The patent employs preliminary crystallization steps before final product isolation. By performing preliminary purification actions during intermediate stages of synthesis, impurities are removed early in the process, preventing their carryover to final product and simplifying the overall purification requirement
2Productivity
If conventional crystallization methods are used, then the process is faster, but the yield is reduced due to loss of product during purification
Solution Approach 1:
The patent utilizes controlled phase transitions through crystallization from specific solvent systems. By selecting appropriate solvents and controlling crystallization conditions, the product transitions from dissolved state to crystalline form, enabling efficient separation while maximizing recovery. The tartrate salt formation followed by crystallization achieves both purification and high yield retention
Solution Approach 2:
The patent optimizes crystallization parameters including solvent selection, temperature control, and pH adjustment to balance purification efficiency with product recovery. By carefully controlling these parameters, the process achieves thorough impurity removal while minimizing product loss, thereby maintaining high yield without excessive purification time
3Stability of the object's composition
If the compound is produced without controlled crystallization, then the production process is simpler, but the stability is reduced
Solution Approach 1:
The patent employs controlled crystallization to transform the compound from an amorphous or poorly ordered state to a well-defined crystalline structure. This phase transition to a stable crystal form enhances the compound's stability for storage and handling, while the crystallization process itself is implemented through straightforward procedures using common solvents and equipment
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively reduces impurity levels, increases yield, and stabilizes the compound, allowing for high-purity production of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide, particularly in the crystalline Form C, suitable for pharmaceutical applications.
Implementation Method 1
reacting the 4-isobutoxybenzaldehyde with about 1.5 equivalents of NH2OH to produce 4-isobutoxybenzoxime, reacting the 4-isobutoxybenxoxime with H2 in the presence of Raney-Ni and from about 13 to about 16 equivalents of NH3 to produce (4-isobutoxyphenyl)methanamino acetate
Implementation Method 2
controlled crystallization to obtain crystalline Form C, which minimizes impurities and enhances purity
Data Source
AI summary
Disclosed herein are methods for synthesizing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide. Also disclosed herein is the hemi-tartrate salt of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)-phenylmethyl)carbamide and methods for obtaining the salt. Further disclosed are various crystalline forms of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its hemi-tartrate salt including various polymorphs and solvates.